KNOWLEDGE AND ATTITUDE ABOUT MUCORMYCOSIS AMONG DENTIST IN UTTAR PRADESH- A QUESTIONNAIRE BASED STUDY
Keywords:
Mucormycosis, Fungal Infection, DentistAbstract
Mucormycosis is a severe fungal infection with high mortality and morbidity rates. This study aimed to assess the knowledge and attitude of dentists in Uttar Pradesh towards mucormycosis, a condition caused by Mucorales fungi. The clinical manifestations include various types such as rhino-orbital-cerebral, pulmonary, gastrointestinal, cutaneous, renal, and disseminated mucormycosis. A cross-sectional study was conducted among dentists in Kanpur, Uttar Pradesh, using a validated questionnaire. The sample size was 120, comprising BDS and MDS graduates, postgraduate students, and academicians. Data collection was done through offline distribution and online surveys via Google Form. A total of 120 dentists participates in the research. Among them 65% were MDS, whereas 35% were BDS. The study revealed that 76.7% of participants recognized mucormycosis as a very dangerous condition and 70.0% of them thought that Dentist can play a major role in teaching other persons about mucormycosis.
Downloads
References
Nicolatou‐Galitis O, Sachanas S, Drogari‐Apiranthitou M, Moschogiannis M, Galiti D,
Yiakoumis X, Rontogianni D, Yiotakis I, Petrikkos G, Pangalis G. Mucormycosis presenting
with dental pain and palatal ulcer in a patient with chronic myelomonocytic leukaemia: case
report and literature review. JMM Case Reports. 2015 Feb;2(1):e000014.
Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and diagnosis of mucormycosis:
an update. Journal of fungi. 2020 Nov 2;6(4):265.
Chakraborty R, Pandya D, Dausage P, Chawla AK. Mucormycosis - The deadly fungus –A case
report with dental perspective. J Family Med Prim Care 2022;11:1532-5.
Gupta A, Sharma A, Chakrabarti A. The emergence of post-COVID-19 mucormycosis in
India: Can we prevent it? Indian J Ophthalmol 2021;69:1645-7.
Prakash H, Chakrabarti A. Epidemiology of Mucormycosis in India. Microorganisms. 2021
Mar 4;9(3):523.
Aranjani JM, Manuel A, Abdul Razack HI, Mathew ST (2021) COVID-19–associated
mucormycosis: Evidence-based critical review of an emerging infection burden during the
pandemic’s second wave in India. PLoS Negl Trop Dis 15(11): e0009921.
GovernmentStats. Mucormycosis—Black Fungus: Daily Dashboard—Total Cases for India.
Aug 3 [cited 2021 Sept 2]. Mondat.
Arpit Sikri., et al. “COVID-19 and Mucormycosis in Dental Practice: Let’s Decipher the
Enigma!: A Review". Scientific Archives Of Dental Sciences 4.7 (2021): 54-57.
Anuraaga AT, Sharmila.D, Reddy VR, Chowdhary DS, Rajashekaran S, Shaji NE.
Knowledge, Awareness And Attitude About Mucormycosis Among Dentists. Eur. Chem. Bull.
, 12(special Issue 5), 5286 – 5292.
Aswal GS, Rawat R, Dwivedi D, Prabhakar N, Kumar KRV. Diagnosis and management of
mucormycosis in the dental clinic: A guide for oral health professionals in India. J Family Med
Prim Care. 2022 Aug;11(8):4293-4298.
Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID-19: A systematic review
of cases reported worldwide and in India. Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146.
Dongre P, Bansal T. Role of dentist in diagnosis and management of mucormycosis in
association with COVID-19. Journal of Oral Research and Review. 2022 Jul 1;14(2):150-163.
Jayagayathri R, Mohanty P, Yadalla D, Bakthavatchalam J, Rangarajan V, Maneksha V, et
al. Knowledge, attitude, and practice toward mucormycosis among patients presenting to six
tertiary eye care hospitals in South India – A multicentric online questionnaire-based survey.
Indian J Ophthalmol 2022;70:2158-62.
Oladele R, Otu AA, Olubamwo O, Makanjuola OB, Ochang EA, Ejembi J, Irurhe N,
Ajanaku I, Ekundayo HA, Olayinka A, Atoyebi O, Denning D. Evaluation of knowledge and
awareness of invasive fungal infections amongst resident doctors in Nigeria. Pan Afr Med J.
Aug 18;36:297.
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
